Zacks Investment Research
05 Nov 2026, 13:51 UTC · 4h ago
Impact · against what's priced in
The recent price surge in OFIX appears to be speculative anticipation of Q3 earnings rather than a reaction to fundamental shifts. With consensus estimates projecting a 45% YoY decline in EPS, the current upward momentum is not supported by the projected financial results.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish · 1 new · 2 priced in
Orthofix is expected to report third quarter 2026 earnings of $0.11 per share, a 45% year-over-year decrease.
Priced inanalysis of consensus estimates for Nov 9 report
So whatA 45% decline in EPS suggests significant margin compression or higher OpEx compared to Q3 2025.
More negative than 86% of claims this week
Orthofix shares rose 11% to $9.72 in the last trading session on higher-than-average volume.
Continue reading
5 related stories
While the stock rose 11% on optimism, the underlying consensus estimates remain bleak, projecting a 45% year-over-year decrease in earnings per share to $0.11.
Read from the article alone
No priced-in read yet
The article mentions Mass Resonance only as a peer in the medical instruments industry and provides no company-specific fundamental data.
Read from the article alone
Scored by the NIS engine · methodology.
Top 2 movers · tap to explore
Newreported as 'ended the last trading session'
So whatThe price surge offsets the 6.9% loss seen over the prior four weeks.
More positive than 61% of claims this week
The Zacks Consensus Estimate for Orthofix's third quarter revenue is $210.43 million, representing a 2.3% increase.
Priced inanalysis of consensus estimates for Nov 9 report
So whatLow single-digit growth suggests the company is struggling to scale top-line revenue in the current quarter.
More positive than 48% of claims this week
Which stocks this story touches
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
47m ago
−9.2%
Price agrees with the score
$8.82 vs $9.72 close before publication (Nov 4) · not market-adjusted
OFIX chart →−9.8%
$9.99 vs $11.07 close before publication (Nov 4) · not market-adjusted
MASS chart →
